CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Cash flows from operating activities:
Net income (loss)	$ 2,016	$ 1,824
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Transaction and credit losses	656	840
Depreciation and amortization	528	539
Stock-based compensation	663	708
Deferred income taxes	29	(146)
Net (gains) losses on strategic investments	55	(181)
Accretion of discounts on investments, net of amortization of premiums	(197)	(162)
Adjustments to loans and interest receivable, held for sale	64	34
Other	(42)	(114)
Originations of loans receivable, held for sale	(11,065)	(1,521)
Proceeds from repayments and sales of loans receivable, originally classified as held for sale	11,175	302
Changes in assets and liabilities:
Accounts receivable	82	36
Accounts payable	(11)	(12)
Other assets and liabilities	(511)	(1,177)
Net cash provided by operating activities	3,442	970
Cash flows from investing activities:
Purchases of property and equipment	(311)	(320)
Proceeds from sales of property and equipment	0	40
Purchases and originations of loans receivable	(9,961)	(15,167)
Proceeds from repayments and sales of loans receivable, originally classified as held for investment	9,760	15,990
Purchases of investments	(16,004)	(10,523)
Maturities and sales of investments	14,241	10,742
Funds receivable	(1,367)	759
Collateral posted related to derivative instruments, net	75	(11)
Other	(100)	83
Net cash (used in) provided by investing activities	(3,667)	1,593
Cash flows from financing activities:
Proceeds from issuance of common stock	55	82
Purchases of treasury stock	(3,002)	(2,961)
Tax withholdings related to net share settlements of equity awards	(230)	(200)
Borrowings under financing arrangements	1,414	720
Repayments under financing arrangements	(411)	(942)
Funds payable and amounts due to customers	(38)	(2,578)
Collateral received related to derivative instruments, net	70	(175)
Other	(20)	0
Net cash used in financing activities	(2,162)	(6,054)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	(89)	(50)
Net change in cash, cash equivalents, and restricted cash	(2,476)	(3,541)
Cash, cash equivalents, and restricted cash at beginning of period	21,834	19,156
Cash, cash equivalents, and restricted cash at end of period	19,358	15,615
Supplemental cash flow disclosures:
Cash paid for interest	166	167
Cash paid for income taxes, net	822	906
The table below reconciles cash, cash equivalents, and restricted cash as reported in the condensed consolidated balance sheets to the total of the same amounts shown in the condensed consolidated statements of cash flows:
Cash and cash equivalents	7,701	5,504
Total cash, cash equivalents, and restricted cash shown in the condensed consolidated statements of cash flows	19,358	15,615
Short-term investments
The table below reconciles cash, cash equivalents, and restricted cash as reported in the condensed consolidated balance sheets to the total of the same amounts shown in the condensed consolidated statements of cash flows:
Restricted cash and cash equivalents	3	11
Funds receivable and customer accounts
The table below reconciles cash, cash equivalents, and restricted cash as reported in the condensed consolidated balance sheets to the total of the same amounts shown in the condensed consolidated statements of cash flows:
Restricted cash and cash equivalents	$ 11,654	$ 10,100